Suzhou Basecare Medical's quarterly market cap
declined
from Dec. 2022 (HK$1,020.3 Mil) to Jun. 2023 (HK$776.8 Mil) and
declined
from Jun. 2023 (HK$776.8 Mil) to Dec. 2023 (HK$642.8 Mil).
Suzhou Basecare Medical's annual market cap
declined
from Dec. 2021 (HK$1,832.6 Mil) to Dec. 2022 (HK$1,020.3 Mil) and
declined
from Dec. 2022 (HK$1,020.3 Mil) to Dec. 2023 (HK$642.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Suzhou Basecare Medical's Enterprise Value for Today is HK$-181.1 Mil.
Suzhou Basecare Medical Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Suzhou Basecare Medical's Market Cap
For the Medical Devices subindustry, Suzhou Basecare Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Basecare Medical's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Suzhou Basecare Medical's Market Cap falls into.
Suzhou Basecare Medical Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Suzhou Basecare Medical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Basecare Medical (HKSE:02170) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Suzhou Basecare Medical Market Cap Related Terms
Thank you for viewing the detailed overview of Suzhou Basecare Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Suzhou Basecare Medical (HKSE:02170) Business Description
Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02170 has been successfully added to your 